MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (consumer products)
- BAJAJ CONSUMER CARE
BAJAJ CONSUMER CARE Share Price (BAJCL)
Here is the latest stock price and chart of BAJAJ CORP. For more details, see the BAJAJ CORP company fact sheet and quarterly results. For a sector overview, read our consumer products sector report.
| Live BSE Quotes | Nov 14, 2019 (Close) | ||
|---|---|---|---|
| Price (Rs)240.30 | Open (Rs) 242.80 | High (Rs) 248.20 | Low (Rs) 239.65 |
| % Change-0.48 | Volume 42,708 | Value (Rs) 10,387,150 | 52-Week H/L 398.00 / 193.00 |
| Live NSE Quotes | Nov 14, 2019 3:29:58 PM | ||
|---|---|---|---|
| Price (Rs)241.00 | Open (Rs) 242.50 | High (Rs) 248.95 | Low (Rs) 240.00 |
| % Change-1.45 | Volume 141,706 | Value (Rs) 34,488,406 | 52-Week H/L 525.00 / 340.00 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 16.05 | P/E Ratio (x) 14.98 | Market Cap (Rs m) 35,444.25 | P/BV (x) 7.58 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
BAJAJ CONSUMER CARE Share Price Today:
BAJAJ CONSUMER CARE last traded price was down 0.5% to Rs 240.3 on the BSE. On the NSE, BAJAJ CONSUMER CARE last traded price was down 1.5% to Rs 241.0. The total volume of shares traded was 0.2 m.
Overall, the broader S&P BSE FMCG Index was down by 0.5%. And the benchmark S&P BSE SENSEX was at 40,286.5 (up 0.4%).
Over the last 30 days, the BAJAJ CONSUMER CARE share price is up 4.7%. And over the last one year, BAJAJ CONSUMER CARE share price is down 31.9%.
|
| |
Today's Market
Sensex Ends 170 Points Higher; IT and Banking Stocks Witness Buying(Closing)
Indian share markets traded on a volatile note throughout the day and ended higher. Benchmark Indices were highly volatile swinging between positive and negative territory.
Related Views On News
BAJAJ CONSUMER CARE Announces Quarterly Results (2QFY20); Net Profit Up 10.9% (Quarterly Result Update)
Oct 14, 2019 | Updated on Oct 14, 2019For the quarter ended September 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (up 10.9% YoY). Sales on the other hand came in at Rs 2 bn (up 2.1% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
BAJAJ CONSUMER CARE Announces Quarterly Results (1QFY20); Net Profit Up 9.1% (Quarterly Result Update)
Jul 17, 2019 | Updated on Jul 17, 2019For the quarter ended June 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 587 m (up 9.1% YoY). Sales on the other hand came in at Rs 2 bn (up 8.5% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
BAJAJ CONSUMER CARE 2018-19 Annual Report Analysis (Annual Result Update)
Jun 24, 2019 | Updated on Jun 24, 2019Here's an analysis of the annual report of BAJAJ CONSUMER CARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BAJAJ CONSUMER CARE. Also includes updates on the valuation of BAJAJ CONSUMER CARE.
BAJAJ CORP 2017-18 Annual Report Analysis (Annual Result Update)
Aug 21, 2018 | Updated on Aug 21, 2018Here's an analysis of the annual report of BAJAJ CORP for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of BAJAJ CORP. Also includes updates on the valuation of BAJAJ CORP.
More Views on NewsMost Popular
Is Hawkins Set to Become Our Next Superhero Stock? (The 5 Minute Wrapup)
Nov 1, 2019After PI Industries, Hawkins has put up a stellar show so far.
Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints? (Profit Hunter)
Nov 7, 2019Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?
These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound (Profit Hunter)
Nov 5, 2019How to avoid the most common investing mistake and make the most of the smallcap rebound.
Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks (The 5 Minute Wrapup)
Nov 8, 2019Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.
The Top Stocks for 2020 Pass This Most Critical Metric (The 5 Minute Wrapup)
Nov 5, 2019Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.
MoreTRACK BAJAJ CONSUMER CARE
- Track your investment in BAJAJ CONSUMER CARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON BAJAJ CONSUMER CARE
BAJAJ CONSUMER CARE 8-QTR ANALYSIS
COMPARE BAJAJ CONSUMER CARE WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.